As of October 2024, Cytokinetics has a market cap of $5.49B. This makes Cytokinetics the world's 2591th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $7.65B | -6.59% |
2023 | $8.19B | 82.21% |
2022 | $4.49B | 0.53% |
2021 | $4.47B | 119.35% |
2020 | $2.04B | 95.85% |
2019 | $1.04B | 67.88% |
2018 | $619.70M | -22.45% |
2017 | $799.14M | -32.92% |
2016 | $1.19B | 16.16% |
2015 | $1.03B | 30.59% |
2014 | $785.41M | 23.23% |
2013 | $637.35M | 64.14% |
2012 | $388.29M | -31.25% |
2011 | $564.79M | -54.07% |
2010 | $1.23B | -28.18% |
2009 | $1.71B | 2.11% |
2008 | $1.68B | -39.75% |
2007 | $2.78B | -36.76% |
2006 | $4.40B | 14.72% |
2005 | $3.84B | -36.39% |
2004 | $6.03B | - |